- Report
- March 2025
- 200 Pages
Global
From €4008EUR$4,490USD£3,507GBP
- Report
- June 2025
Global
From €4374EUR$4,900USD£3,827GBP
- Report
- May 2025
- 180 Pages
Global
From €3165EUR$3,545USD£2,769GBP
€3517EUR$3,939USD£3,077GBP
- Report
- November 2024
- 100 Pages
Global
From €5312EUR$5,950USD£4,647GBP
- Report
- February 2025
- 200 Pages
Global
From €4008EUR$4,490USD£3,507GBP
- Report
- April 2025
- 200 Pages
Global
From €4008EUR$4,490USD£3,507GBP
- Report
- February 2025
- 200 Pages
Global
From €4008EUR$4,490USD£3,507GBP
- Report
- August 2025
- 481 Pages
Global
From €5223EUR$5,850USD£4,569GBP
- Report
- August 2025
- 194 Pages
Global
From €5223EUR$5,850USD£4,569GBP
- Report
- July 2025
- 175 Pages
Global
From €4008EUR$4,490USD£3,507GBP
- Report
- April 2025
- 175 Pages
Global
From €4008EUR$4,490USD£3,507GBP
- Report
- April 2025
- 141 Pages
Global
From €2677EUR$2,999USD£2,342GBP
- Report
- August 2025
- 498 Pages
Global
From €5223EUR$5,850USD£4,569GBP
- Report
- August 2025
- 384 Pages
Global
From €5223EUR$5,850USD£4,569GBP
- Report
- August 2025
- 584 Pages
Global
From €5223EUR$5,850USD£4,569GBP
- Report
- August 2025
- 638 Pages
Global
From €5223EUR$5,850USD£4,569GBP
- Report
- June 2025
- 400 Pages
Global
From €4418EUR$4,949USD£3,865GBP
- Report
- July 2025
- 210 Pages
Global
From €4459EUR$4,995USD£3,901GBP
- Report
- June 2025
- 260 Pages
Global
From €4459EUR$4,995USD£3,901GBP
- Report
- May 2023
- 187 Pages
Global
From €4673EUR$5,418USD£3,950GBP

Allergic rhinitis, commonly known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air. Within the context of allergy and immunology, it is considered one of the most common conditions, affecting a substantial portion of the population. The market consists of various diagnostic and therapeutic options designed to manage and alleviate the symptoms of allergic rhinitis, which include sneezing, congestion, runny nose, and itchy eyes. Diagnostic methods range from skin prick tests to specific IgE blood tests, which help in identifying the allergens causing the symptoms.
Treatment typically involves allergen avoidance strategies, pharmacotherapy, and immunotherapy. Pharmacologic treatments include antihistamines, decongestants, nasal corticosteroids, and leukotriene receptor antagonists. Subcutaneous and sublingual immunotherapies are approaches to desensitize the body's response to specific allergens. The market is driven by research and development of new treatments, improved diagnostics, and the rising prevalence of allergic diseases.
Several companies that operate in the allergic rhinitis market include Merck & Co., Sanofi, GlaxoSmithKline, Johnson & Johnson, Novartis, AstraZeneca, and Pfizer. These entities engage in the manufacture and distribution of various medications, and some also provide immunotherapy options. These companies play a pivotal role in advancing the field of allergy and immunology through continuous Show Less Read more